A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium) in migraine.
D000328:Adult; D002936:Cinnarizine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005444:Flunarizine; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000517:prevention & control*; D010879:Piperazines / Q000627:therapeutic use*; D012737:Sex Factors; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use*
D010879:Piperazines; D014665:Vasodilator Agents; D002936:Cinnarizine; D005444:Flunarizine